Your browser doesn't support javascript.
loading
Therapeutic plasma exchange as a novel treatment for severe intrahepatic cholestasis of pregnancy: Case series and mechanism of action.
Ovadia, Caroline; Lövgren-Sandblom, Anita; Edwards, Lindsey A; Langedijk, Jacqueline; Geenes, Victoria; Chambers, Jenny; Cheng, Floria; Clarke, Louise; Begum, Shahina; Noori, Muna; Pusey, Charles; Padmagirison, Radhika; Agarwal, Sangita; Peerless, James; Cheesman, Kate; Heneghan, Michael; Oude Elferink, Ronald; Patel, Vishal C; Marschall, Hanns-Ulrich; Williamson, Catherine.
Afiliação
  • Ovadia C; Department of Women and Children's Health, King's College London, London, United Kingdom.
  • Lövgren-Sandblom A; Department of Clinical Chemistry, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Edwards LA; Division of Transplantation, Immunology and Mucosal Biology, King's College London, London, United Kingdom.
  • Langedijk J; Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands.
  • Geenes V; Department of Women and Children's Health, King's College London, London, United Kingdom.
  • Chambers J; Department of Women and Children's Health, King's College London, London, United Kingdom.
  • Cheng F; Women's Health Research Centre, Imperial College London, London, United Kingdom.
  • Clarke L; Women's Health Research Centre, Imperial College London, London, United Kingdom.
  • Begum S; Department of Women and Children's Health, King's College London, London, United Kingdom.
  • Noori M; Department of Women and Children's Health, King's College London, London, United Kingdom.
  • Pusey C; Department of Obstetrics and Gynaecology, Imperial College Hospitals, London, United Kingdom.
  • Padmagirison R; Department of Medicine, Imperial College London, London, United Kingdom.
  • Agarwal S; Department of Obstetrics and Gynaecology, Lister Hospital, Stevenage, Hertfordshire, United Kingdom.
  • Peerless J; Department of Rheumatology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Cheesman K; Department of Anaesthetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Heneghan M; Department of Anaesthetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Oude Elferink R; Division of Transplantation, Immunology and Mucosal Biology, King's College London, London, United Kingdom.
  • Patel VC; Academic Medical Center, Tytgat Institute for Liver and Intestinal Research, Amsterdam, The Netherlands.
  • Marschall HU; Division of Transplantation, Immunology and Mucosal Biology, King's College London, London, United Kingdom.
  • Williamson C; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden.
J Clin Apher ; 33(6): 638-644, 2018 Dec.
Article em En | MEDLINE | ID: mdl-30321466
ABSTRACT

INTRODUCTION:

Intrahepatic cholestasis of pregnancy is characterised by pruritus and elevated serum bile acids. The pruritus can be severe, and pharmacological options achieve inconsistent symptomatic improvement. Raised bile acids are linearly associated with adverse fetal outcomes, with existing management of limited benefit. We hypothesised that therapeutic plasma exchange removes pruritogens and lowers total bile acid concentrations, and improves symptoms and biochemical abnormalities in severe cases that have not responded to other treatments.

METHODS:

Four women with severe pruritus and hypercholanemia were managed with therapeutic plasma exchange. Serial blood biochemistry and visual analogue scores of itch severity were obtained. Blood and waste plasma samples were collected before and after exchange; individual bile acids and sulfated progesterone metabolites were measured with HPLC-MS, autotaxin activity and cytokine profiles with enzymatic methods. Results were analysed using segmental linear regression to describe longitudinal trends, and ratio t tests.

RESULTS:

Total bile acids and visual analogue itch scores demonstrated trends to transiently improve following plasma exchange, with temporary symptomatic benefit reported. Individual bile acids (excluding the drug ursodeoxycholic acid), and the sulfated metabolites of progesterone reduced following exchange (P = .03 and P = .04, respectively), whilst analysis of waste plasma demonstrated removal of autotaxin and cytokines.

CONCLUSIONS:

Therapeutic plasma exchange can lower potentially harmful bile acids and improve itch, likely secondary to the demonstrated removal of pruritogens. However, the limited current experience and potential complications, along with minimal sustained symptomatic benefit, restrict its current use to women with the most severe disease for whom other treatment options have been exhausted.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Complicações na Gravidez / Colestase Intra-Hepática Tipo de estudo: Etiology_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Apher Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Troca Plasmática / Complicações na Gravidez / Colestase Intra-Hepática Tipo de estudo: Etiology_studies Limite: Female / Humans / Pregnancy Idioma: En Revista: J Clin Apher Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido